May. 28 at 7:04 PM
$LSH We're pleased with the early synergies & initial contribution from Huiyu Pharmaceutical, which is a cornerstone of our diversification strategy.
We're leveraging our logistics expertise to optimize Huiyu's supply chain in China & building partnerships with major players like Kelun Pharmaceutical.
The Chinese healthcare market is growing significantly, and we believe Huiyu is well-positioned to capture a meaningful share of this growth, driving revenue and profitability for Lakeside.